Menopausal women who took estrogen and progesterone faced a small increased risk for cancer for more than two years after they stopped taking the pills, researchers said on Tuesday.
Want to walk for a good cause but find yourself strapped for time or physically incapable? Welcome to the virtual walk where you can raise money for charity without ever stepping out the front door.
Dendreon Corp. (Nasdaq: DNDN) said its breast cancer vaccine Neuvenge appeared to be safe, according to results of an initial study.
GlaxoSmithKine plc has announced today the submission of a New Drug Application to the United States Food and Drug Administration (FDA), for approval to market.
German drugmaker Schering has entered into a deal with AstraZeneca to jointly develop a new breast cancer drug